Cheng Hui, Jiang Meiye, Kim Sohyoung, Moshiri Arfa, Dar Mohd Saleem, Akhtar Jawad, Saloura Vassiliki
Head and Neck Surgery Branch, National Institutes of Deafness and Communication Disorders, NIDCD, NIH, United States.
Thoracic and Gl Malignancies Branch, Center for Cancer Research, National Cancer Institute, United States.
Oral Oncol. 2025 Sep 19;170:107687. doi: 10.1016/j.oraloncology.2025.107687.
Chromatin factors, defined here as proteins that chemically modify the DNA and histones, remodel chromatin and regulate nucleosome occupancy, play central roles in the transcriptional regulation of genes and are implicated in cancer initiation and progression in multiple cancer types. To systematically investigate the genomic and expression alterations of chromatin factors in head and neck squamous cell carcinoma (HNSCC), we utilized the molecular profiles from 530 HNSCC tumor samples in the Cancer Genome Atlas (TCGA), and characterized the mutational, copy number and transcriptional alterations of 422 chromatin factors, as well as their correlation with the "cold" tumor phenotype in HPV-negative and HPV-positive HNSCC. Histone-lysine N-methyltransferase 2D (MLL2) was the most frequently mutated chromatin factor in both HPV-negative and HPV-positive HNSCC, with mutation frequencies of 12-17 %. Actin Like 6A (ACTL6A), a component of the SWI/SNF chromatin remodeling complex, was the most frequently copy-number amplified chromatin factor in both HPV-negative and HPV-positive HNSCC, with amplification frequencies of 19-24 %. Double PHD Fingers 1 (DPF1), a component of the chromatin remodeling complex, and Ubiquitin Like With PHD AndRing Finger Domains1 (UHRF1) were the most overexpressed chromatin factors in HPV-negative and HPV-positive HNSCC tumors respectively. Components of the chromatin remodeling complex, such as ACTL6A, SMARCA1 and MORF4L2, were correlated with the "cold" tumor phenotype in both HPV-negative and HPV-positive HNSCC. This brief study highlights epigenetic chromatin factors that may drive oncogenesis and immune evasion, thereby identifying novel targets for cancer therapy in clearly defined, epigenetically-driven subtypes of HPV-negative and HPV-positive HNSCC.
染色质因子在此被定义为对DNA和组蛋白进行化学修饰、重塑染色质并调节核小体占有率的蛋白质,其在基因的转录调控中发挥核心作用,并且与多种癌症类型的发生和进展有关。为了系统地研究头颈部鳞状细胞癌(HNSCC)中染色质因子的基因组和表达改变,我们利用了癌症基因组图谱(TCGA)中530例HNSCC肿瘤样本的分子谱,对422个染色质因子的突变、拷贝数和转录改变进行了表征,以及它们与HPV阴性和HPV阳性HNSCC中“冷”肿瘤表型的相关性。组蛋白赖氨酸N-甲基转移酶2D(MLL2)是HPV阴性和HPV阳性HNSCC中最常发生突变的染色质因子,突变频率为12%-17%。肌动蛋白样6A(ACTL6A)是SWI/SNF染色质重塑复合物的一个组成部分,是HPV阴性和HPV阳性HNSCC中最常发生拷贝数扩增的染色质因子,扩增频率为19%-24%。染色质重塑复合物的一个组成部分双PHD指蛋白1(DPF1)和含PHD和指环结构域的泛素样蛋白1(UHRF1)分别是HPV阴性和HPV阳性HNSCC肿瘤中最过度表达的染色质因子。染色质重塑复合物的组成部分,如ACTL6A、SMARCA1和MORF4L2,在HPV阴性和HPV阳性HNSCC中均与“冷”肿瘤表型相关。这项简短的研究突出了可能驱动肿瘤发生和免疫逃逸的表观遗传染色质因子,从而在明确界定的、表观遗传驱动的HPV阴性和HPV阳性HNSCC亚型中确定了癌症治疗的新靶点。